Advanced search×

Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.

E A Haavardsholm, M Østergaard, H B Hammer, P Bøyesen, A Boonen, D van der Heijde, and T K Kvien

Ann Rheum Dis 68(10):1572-9 (2009) PMID 19019893

To evaluate the responsiveness of magnetic resonance imaging (MRI) and ultrasonography (US) compared with conventional measures of disease activity and structural damage in patients with rheumatoid arthritis (RA) during the first year of treatment with anti-tumour necrosis factor alpha (TNFalpha).

DOI: 10.1136/ard.2008.091801
Version: za2963e q8za1 q8zbd q8zca q8zd4 q8zec q8zfd q8zg7

Similar articles you may find interesting…

  1. Recombinant hormones in osteoporosis.
    Lars Rejnmark

    Expert Opin Biol Ther (2013) PMID 23646915

    For the last 10 years, bone anabolic therapy with the recombinant human parathyroid hormone (rhPTH) analogue, teriparatide (rhPTH[1-34]), or full-length rhPTH(1-84) has been an option in the treatment of osteoporosis. Both drugs are given as a daily subcutaneous injection. In the USA, only teriparat...
  2. Long-term antinociception by electroacupuncture is mediated via peripheral opioid receptors in free-moving rats with inflammatory hyperalges...
    Y Wang, D Hackel, and H L Rittner

    Eur J Pain (2013) PMID 23649949

    By employing a reproducible EA treatment model on GB30 in free-moving rats, we demonstrated the involvement of peripheral opioid receptors mediated EA-induced long-term antinociception. Future studies should examine the specific neuroimmunological connection of EA-induced sustained antinociception i...
  3. Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma ...
    Emily L Williams, Stuart N Dunn, and Juliet C Gray

    Clin Cancer Res (2013) PMID 23649004

    These data suggest the combination of antigen and co-stimulatory mAb may provide effective immunotherapy against neuroblastoma and may be of particular use in the minimal-residual disease setting....